۲ݮƵ

Appointment of Dr. Nathaniel Bouganim as the MUHC Division Director for Medical Oncology

Congratulations to Dr. Nathaniel Bouganim for his appointment as the MUHC Division Director for Medical Oncology.

Dr. Nathaniel Bouganim is an Assistant Professor in the Gerald Bronfman Department of Oncology. He completed his training in internal medicine and oncology at ۲ݮƵ University and his sub-specialty training in breast cancer, focusing on bone metastases and “patient centered care” with Dr. Mark Clemons at the Ottawa Integrative Cancer Centre and the National Cancer Institute of Canada (NCIC).

He joined the ۲ݮƵ University Health Centre (MUHC) in 2011 as a medical oncologist specializing in breast cancer and head and neck cancers. He currently serves as the Director of the Oncology in-patient teaching unit at the MUHC. Dr. Bouganim is a very active researcher with multiple investigator led clinical trials, and is principal investigator on numerous phase 1, 2 and 3 clinical trials in both breast and head and neck cancers. He is a founding member of the scientific committee for the McPeak Sirois group for clinical research in breast cancer as well as a member of the Comité d'évolution des pratiques en oncologie (CEPO) guideline committee. In addition, he has served as a breast cancer expert for Quebec’s Institut national d’excellence en santé et en services sociaux (INESS).

Back to top